Skip to content
Screener

Iovance Biotherapeutics, Inc. IOVA Current ratio

Current ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
1.5×+0.3×
Gilead Sciences logo
Gilead SciencesGILD
1.3×0.0×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
6.7×+4.4×
CTO
Citius Oncology, Inc.CTOR
0.5×+0.1×
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
8.4×-1.4×
Artiva Biotherapeutics, Inc. logo
Artiva Biotherapeutics, Inc.ARTV
24.2×+10.3×

Other financials

Income statement

See full
Revenue$99.3M+65.7%
Gross profit$55.7M+403%
Operating income-$51.9M+54.4%
Net income-$47.3M+57.6%
EPS (diluted)-$0.11+66.7%

Balance sheet

See full
Cash & equivalents$110.8M-16.4%
Total debt$46.0M-11.8%
Total equity$736.0M+5.4%
Total assets$915.5M+0.9%

Cash flow

See full
Operating cash flow-$60.8M+9.8%
CapEx$5.4M-27.1%
Free cash flow-$66.3M+11.5%

Valuation

See full
Market cap$2.77B+222%
Enterprise value$2.71B+247%
P/S8.5×+5.0×

Profitability

See full
Gross margin48.4%+15.0pp
Operating margin-92.7%-29.0pp
Net margin-89.1%-27.6pp
FCF margin-91.2%-22.1pp

Returns & leverage

See full
Return on equity-40.4%-7.8pp
Debt / equity0.1×0.0×

Where this comes from

Calculated from Iovance Biotherapeutics, Inc.’s reported figures.

total current assets/total current liabilities=4.3×

Based on the most recent quarter.

The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 9:15 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-091716

FAQ

What is Iovance Biotherapeutics, Inc.'s current ratio?
Iovance Biotherapeutics, Inc. (IOVA) reported current ratio of 4.3× in Q2 2026.
How has Iovance Biotherapeutics, Inc.'s current ratio changed year-over-year?
Iovance Biotherapeutics, Inc.'s current ratio increased by 32.8% year-over-year, from 3.3× to 4.3×.
What is the long-term trend for Iovance Biotherapeutics, Inc.'s current ratio?
Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s current ratio has grown at a -22.7% compound annual growth rate (CAGR), from 11.6× to 3.2×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Ask your AI about Iovance Biotherapeutics, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude